JPH11515000A - ▲iv▼4型ホスホジエステラーゼ阻害剤としてのキノリン導誘体 - Google Patents
▲iv▼4型ホスホジエステラーゼ阻害剤としてのキノリン導誘体Info
- Publication number
- JPH11515000A JPH11515000A JP9515313A JP51531397A JPH11515000A JP H11515000 A JPH11515000 A JP H11515000A JP 9515313 A JP9515313 A JP 9515313A JP 51531397 A JP51531397 A JP 51531397A JP H11515000 A JPH11515000 A JP H11515000A
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- quinoline
- methyl
- disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.遊離形、N−オキシド形または医薬上許容される酸付加塩もしくはアンモ ニウム塩の形の8−(ベンゾ〔c〕チアジアゾリル、ベンゾ〔c〕フラザニルま たは2−メチル−2H−ベンゾ〔d〕トリアゾリル)キノリン。 2.式I: 〔上式中 Xは−O−,−S−または−N(CH3)−であり、 R1は水素または(C1-4)アルキルであり、そして R2は(C1-4)アルキルまたはピリジルである〕 により表される、遊離形、N−オキシド形または医薬上許容される酸付加塩もし くはアンモニウム塩の形の請求項1に記載の化合物。 3.遊離形、N−オキシド形または医薬上許容される酸付加塩もしくはアンモ ニウム塩の形の i) 8−(ベンゾ〔c〕フラザン−4−イル)−6−(ピリジン−4−イル )キノリン ii) 8−(ベンゾ〔c〕フラザン−4−イル)−3−メチル−6−(ピリジ ン−4−イル)キノリン iii) 8−(ベンゾ〔c〕フラザン−3−イル)−6−(ピリジン−4−イル メチル)キノリン iv) 8−(ベンゾ〔c〕チアジアゾール−4−イル)−6−(ピリジン−4 −イル)キノリン v) 8−(ベンゾ〔c〕チアジアゾール−4−イル)−3−メチル−6−( ピリジン−4−イル)キノリン vi) 8−(2−メチル−2H−ベンゾ〔d〕トリアゾール−5−イル)−6 −(ピリジン−4−イルメチル)キノリン から選ばれる、請求項1または2に記載の化合物。 4.医薬として用いられる、請求項1,2または3に記載の化合物。 5.場合により医薬上許容される担体または希釈剤と共同して、請求項1,2 または3に記載の化合物を含んで成る医薬組成物。 6.a)閉塞性または炎症性気道疾患 b)炎症性もしくは自己免疫性の疾患または状態 e)うつ病、アルツハイマー病、パーキンソン病または発作の処置のため の医薬の製造における、請求項1,2または3のいずれか一項に記載の化合物の 使用。 7.a)閉塞性または炎症性気道疾患 b)炎症性もしくは自己免疫性の疾患または状態 e)うつ病、アルツハイマー病、パーキンソン病または発作の処置方法で あって、請求項1,2または3に記載の化合物の有効量を前記処置の必要な患者 に投与することを含んで成る方法。 8.次の段階: (i)3−Q−もしくは4−Q−ベンゾ〔c〕チアジアゾール、−ベンゾ〔c 〕フラザンまたは−2−メチル−2H−ベンゾ〔d〕トリアゾールを8−Q′− キノリンと反応させ、ここでQおよびQ′は交差カップリング反応に参加するこ とができる脱離基であり、 (ii)所望により前記生成物をN−アルキル化またはN−オキシ ド化し、そして こうして得られた化合物を遊離形、N−オキシド形または医薬上許容される酸 付加塩もしくはアンモニウム塩の形で回収するを含んで成る、請求項1,2また は3に記載の化合物の製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9523267.4 | 1995-11-14 | ||
GBGB9523267.4A GB9523267D0 (en) | 1995-11-14 | 1995-11-14 | Organic compounds |
PCT/EP1996/004978 WO1997018208A1 (en) | 1995-11-14 | 1996-11-13 | Quinoline derivatives as type iv phosphodiesterase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11515000A true JPH11515000A (ja) | 1999-12-21 |
Family
ID=10783856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9515313A Withdrawn JPH11515000A (ja) | 1995-11-14 | 1996-11-13 | ▲iv▼4型ホスホジエステラーゼ阻害剤としてのキノリン導誘体 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0873338A1 (ja) |
JP (1) | JPH11515000A (ja) |
KR (1) | KR19990067574A (ja) |
CN (1) | CN1202170A (ja) |
AU (1) | AU7570996A (ja) |
BR (1) | BR9611504A (ja) |
CA (1) | CA2235126A1 (ja) |
CO (1) | CO4770973A1 (ja) |
CZ (1) | CZ149498A3 (ja) |
GB (1) | GB9523267D0 (ja) |
HU (1) | HUP9903492A3 (ja) |
MX (1) | MX9803839A (ja) |
PE (1) | PE17598A1 (ja) |
PL (1) | PL326636A1 (ja) |
SK (1) | SK63998A3 (ja) |
TR (1) | TR199800851T2 (ja) |
WO (1) | WO1997018208A1 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100701904B1 (ko) | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
CN1520313A (zh) | 2001-05-23 | 2004-08-11 | ������ҩ��ʽ���� | 一种加速骨折愈合的组合物 |
CA2447618A1 (en) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for regenerative treatment of cartilage disease |
TW200536851A (en) * | 2004-01-23 | 2005-11-16 | Amgen Inc | Compounds and methods of use |
JP2006347936A (ja) * | 2005-06-15 | 2006-12-28 | Bayer Cropscience Ag | 殺虫性ベンズアニリド類 |
AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
EP2569285A1 (en) | 2010-05-10 | 2013-03-20 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
AR093017A1 (es) | 2012-10-16 | 2015-05-13 | Janssen Pharmaceutica Nv | MODULARES DE RORgT DE QUINOLINILO UNIDOS POR METILENO |
JP6250686B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ.ベー. | Rorγtのヘテロアリール結合させたキノリニルモジュレータ |
JP6251277B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ.ベー. | ROR−ガンマ−tのフェニル結合キノリニルモジュレーター |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
ES2770727T3 (es) | 2013-10-15 | 2020-07-02 | Janssen Pharmaceutica Nv | Moduladores de quinilonila enlazados a alquilo de ROR(gamma)t |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9624225B2 (en) | 2013-10-15 | 2017-04-18 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORγt |
EP3813532B1 (en) * | 2018-06-24 | 2024-02-28 | Adama Agan Ltd. | Process for the preparation of quinmerac |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
-
1995
- 1995-11-14 GB GBGB9523267.4A patent/GB9523267D0/en active Pending
-
1996
- 1996-11-12 PE PE1996000810A patent/PE17598A1/es not_active Application Discontinuation
- 1996-11-13 CO CO96059775A patent/CO4770973A1/es unknown
- 1996-11-13 SK SK639-98A patent/SK63998A3/sk unknown
- 1996-11-13 BR BR9611504A patent/BR9611504A/pt not_active Application Discontinuation
- 1996-11-13 AU AU75709/96A patent/AU7570996A/en not_active Abandoned
- 1996-11-13 WO PCT/EP1996/004978 patent/WO1997018208A1/en not_active Application Discontinuation
- 1996-11-13 CZ CZ981494A patent/CZ149498A3/cs unknown
- 1996-11-13 EP EP96938196A patent/EP0873338A1/en not_active Withdrawn
- 1996-11-13 KR KR1019980703597A patent/KR19990067574A/ko not_active Application Discontinuation
- 1996-11-13 CN CN96198305A patent/CN1202170A/zh active Pending
- 1996-11-13 PL PL96326636A patent/PL326636A1/xx unknown
- 1996-11-13 CA CA002235126A patent/CA2235126A1/en not_active Abandoned
- 1996-11-13 HU HU9903492A patent/HUP9903492A3/hu unknown
- 1996-11-13 JP JP9515313A patent/JPH11515000A/ja not_active Withdrawn
- 1996-11-13 TR TR1998/00851T patent/TR199800851T2/xx unknown
-
1998
- 1998-05-14 MX MX9803839A patent/MX9803839A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX9803839A (es) | 1998-09-30 |
KR19990067574A (ko) | 1999-08-25 |
CZ149498A3 (cs) | 1998-08-12 |
CA2235126A1 (en) | 1997-05-22 |
GB9523267D0 (en) | 1996-01-17 |
WO1997018208A1 (en) | 1997-05-22 |
AU7570996A (en) | 1997-06-05 |
CO4770973A1 (es) | 1999-04-30 |
SK63998A3 (en) | 1998-10-07 |
HUP9903492A3 (en) | 2000-08-28 |
PL326636A1 (en) | 1998-10-12 |
EP0873338A1 (en) | 1998-10-28 |
CN1202170A (zh) | 1998-12-16 |
PE17598A1 (es) | 1998-04-06 |
TR199800851T2 (xx) | 1998-08-21 |
BR9611504A (pt) | 1999-03-02 |
HUP9903492A2 (en) | 2000-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11515000A (ja) | ▲iv▼4型ホスホジエステラーゼ阻害剤としてのキノリン導誘体 | |
KR101131684B1 (ko) | Pde4 억제제로서의 피롤리딘디온 치환된피페리딘-프탈라존 | |
JP4417622B2 (ja) | Parpの阻害剤として用いるためのチエノ[2,3−c]イソキノリン | |
JP2001502717A (ja) | ナフチリジン誘導体 | |
JP2015514806A (ja) | 血小板凝集を治療するためのプロテアーゼ活性化受容体4(par4)阻害剤としてのイミダゾチアジアゾールおよびイミダゾピリダジン誘導体 | |
IE914325A1 (en) | Novel dihydro-isoquinoline derivatives | |
WO2023046158A1 (zh) | 氮杂喹啉酮类化合物及其医药用途 | |
JPH09501442A (ja) | 免疫抑制剤として有用な炭素環式および複素環式縮合環キノリンカルボン酸 | |
JP2004518727A (ja) | Pde4インヒビターとしてのフタラインオン−ピペリジノ−誘導体 | |
JP2007506740A (ja) | イソキノリノンカリウムチャネル阻害剤 | |
KR19980701668A (ko) | 글리신/nmda 수용체 길항물질의 아자 및 아자 (n-옥시) | |
CA3057408A1 (en) | Heteroaromatic compounds useful in therapy | |
JPH1179996A (ja) | キナゾリン−4−オンampaアンタゴニスト | |
JPH06504992A (ja) | イミダゾピリジンpaf/h↓1拮抗薬 | |
JP3279633B2 (ja) | ピリダジンジオン化合物 | |
JPH03145469A (ja) | 置換イソキノリン及びその利用法 | |
JP2003512466A (ja) | Pde4インヒビターとしてのテトラヒドロチオピランフタラジノン誘導体 | |
JP2002502403A (ja) | ベンゾナフチリジン | |
WO2020001166A1 (zh) | 糖苷类化合物、其制备方法、组合物、应用及中间体 | |
WO1996038146A1 (en) | Water soluble camptothecin analogs | |
PT87604B (pt) | Processo para a preparacao de agentes anti-alergicos e anti-inflamatorios di-hidropiridinicos | |
EP1047699A1 (en) | Platelet adp receptor inhibitors | |
JPH01254678A (ja) | ジヒドロピリジン化合物 | |
JP4452501B2 (ja) | 4−(チオ−またはセレノキサンテン−9−イリデン)−ピペリジンまたはアクリジンの誘導体および選択的5−ht2b受容体アンタゴニストとしてのその使用 | |
JP2003512459A (ja) | Pde4インヒビターとしてのフタラジノン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050927 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051226 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060323 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060613 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060911 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20060911 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20061207 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20061214 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20070111 |